Equitech-Bio
Private Company
Total funding raised: $25.2M
Overview
Equitech-Bio is a young but strategically positioned reagent supplier in the biologics research sector, leveraging over 30 years of industry experience (implied from website content) to provide a broad portfolio of animal-derived products. The company operates a B2B e-commerce platform, offering over 500 products including albumins, animal sera/plasma, IgG, and antisera, with a stated focus on quality, competitive pricing, and customer service. While not a therapeutic developer, it serves as a critical enabler for preclinical research, diagnostics development, and biologics manufacturing across academia and industry. Its rapid catalog expansion and customer-centric model suggest a focus on capturing market share in the specialized research reagents space.
Technology Platform
Specialized collection, processing, and purification of animal-derived biological materials (plasma, serum, albumins, IgG) from over 16 species for research and diagnostic applications.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Competes directly with large life science tools conglomerates (e.g., Thermo Fisher Scientific, MilliporeSigma) and specialized reagent suppliers (e.g., Jackson ImmunoResearch, Cedarline). Differentiation is based on broad species variety, competitive pricing, and customer service, rather than proprietary technology.